Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q3 2025 (September 30)
6holders
1new positions
1sold out
$0.26avg. 13F price*

At the end of Q3 2025, 6 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were LPL Financial LLC ($69K), Jane Street Group, LLC ($13K) and Wolverine Asset Management LLC ($13K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$19
Exits1$7K

All 13F filers, Q2 2025 → Q3 2025: 18,233 shares bought and 17,696 shares sold, net +537 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

LPL Financial LLC — No change 259,115 $69K
Jane Street Group, LLC — Reduce -0.0% 50,265 $13K
Wolverine Asset Management LLC — Add +57.0% 50,011 $13K
Sio Capital Management, LLC — No change 49,998 $12K
Toronto Dominion Bank — Reduce -0.5% 20,518 $5K
UBS Group AG — New 71 $19

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.